Variant report

Variant	nsv583590
Chromosome Location	chr2:168024328-168075621
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:168068591-168068899	HepG2	liver:	n/a	n/a
2	BACH1	chr2:168072149-168072519	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr2:168066274-168066660	IMR90	lung:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
4	CEBPB	chr2:168053567-168053900	IMR90	lung:	n/a	chr2:168053754-168053767 chr2:168053869-168053882 chr2:168053869-168053880
5	CEBPB	chr2:168066996-168067238	IMR90	lung:	n/a	chr2:168067118-168067131 chr2:168067119-168067130
6	CEBPB	chr2:168066288-168066658	HepG2	liver:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
7	CEBPB	chr2:168066329-168066648	MCF-7	breast:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
8	CEBPB	chr2:168054672-168054862	HepG2	liver:	n/a	chr2:168054819-168054830
9	CEBPB	chr2:168066283-168066646	A549	lung:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
10	CEBPB	chr2:168037710-168038055	IMR90	lung:	n/a	n/a
11	CEBPB	chr2:168054671-168054853	H1-hESC	embryonic stem cell:	n/a	chr2:168054819-168054830
12	CEBPB	chr2:168066297-168066645	H1-hESC	embryonic stem cell:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
13	CEBPB	chr2:168066251-168066678	ECC-1	luminal epithelium:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
14	CEBPB	chr2:168052089-168052385	IMR90	lung:	n/a	chr2:168052217-168052228 chr2:168052303-168052320
15	CEBPB	chr2:168066295-168066625	K562	blood:	n/a	chr2:168066466-168066477
16	CEBPB	chr2:168053553-168053939	ECC-1	luminal epithelium:	n/a	chr2:168053754-168053767 chr2:168053869-168053882 chr2:168053869-168053880
17	CEBPB	chr2:168066976-168067279	HepG2	liver:	n/a	chr2:168067118-168067131 chr2:168067119-168067130
18	CEBPB	chr2:168066272-168066572	ECC-1	luminal epithelium:	n/a	chr2:168066466-168066477
19	CEBPB	chr2:168033741-168034070	IMR90	lung:	n/a	n/a
20	CEBPB	chr2:168053490-168053948	ECC-1	luminal epithelium:	n/a	chr2:168053754-168053767 chr2:168053869-168053882 chr2:168053869-168053880
21	CEBPB	chr2:168066351-168066636	Hela-S3	cervix:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
22	CEBPB	chr2:168052066-168052382	HepG2	liver:	n/a	chr2:168052217-168052228 chr2:168052303-168052320
23	CHD1	chr2:168068438-168069007	IMR90	lung:	n/a	n/a
24	CTCF	chr2:168056040-168056190	AG04450	lung:	n/a	n/a
25	CTCF	chr2:168068680-168068830	GM06990	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
26	CTCF	chr2:168068640-168068790	HRPEpiC	eye:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
27	CTCF	chr2:168068678-168068805	A549	lung:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
28	CTCF	chr2:168068592-168068826	ECC-1	luminal epithelium:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
29	CTCF	chr2:168068580-168068730	HFF-Myc	foreskin:	n/a	n/a
30	CTCF	chr2:168068660-168068810	MCF-7	breast:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
31	CTCF	chr2:168068680-168068830	AG09309	skin:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
32	CTCF	chr2:168068580-168068730	RPTEC	kidney:	n/a	n/a
33	CTCF	chr2:168068700-168068850	MCF-7	breast:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
34	CTCF	chr2:168068493-168068965	HepG2	liver:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
35	CTCF	chr2:168068660-168068851	MCF-7	breast:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
36	CTCF	chr2:168068680-168068830	AG04449	skin:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
37	CTCF	chr2:168068700-168068850	HMEC	breast:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
38	CTCF	chr2:168068640-168068790	HFF-Myc	foreskin:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
39	CTCF	chr2:168068700-168068850	BE2_C	brain:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
40	CTCF	chr2:168068649-168068854	K562	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
41	CTCF	chr2:168068340-168068490	HepG2	liver:	n/a	n/a
42	CTCF	chr2:168068680-168068830	WERI-Rb-1	eye:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
43	CTCF	chr2:168068660-168068810	GM06990	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
44	CTCF	chr2:168068676-168068833	GM20000	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
45	CTCF	chr2:168068624-168068891	H1-hESC	embryonic stem cell:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
46	CTCF	chr2:168068680-168068830	Hela-S3	cervix:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
47	CTCF	chr2:168068700-168068850	RPTEC	kidney:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
48	CTCF	chr2:168068740-168068890	HVMF	connective:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
49	CTCF	chr2:168068580-168068730	NHLF	lung:	n/a	n/a
50	CTCF	chr2:168068724-168068772	GM19240	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:168042982-168043032	ProgFib	skin:	n/a
2	chr2:168042982-168043032	SKMC	muscle:	n/a
3	chr2:168042982-168043032	U87	brain:	n/a
4	chr2:168042982-168043032	ECC-1	luminal epithelium:	n/a
5	chr2:168042982-168043032	HRPEpiC	eye:	n/a
6	chr2:168042982-168043032	PFSK-1	brain:	n/a
7	chr2:168042982-168043032	SAEC	small airway:	n/a
8	chr2:168042982-168043032	HCM	heart:	n/a
9	chr2:168042982-168043032	GM12891	blood:	n/a
10	chr2:168042982-168043032	MCF-7	breast:	n/a
11	chr2:168042982-168043032	NB4	blood:	n/a
12	chr2:168042982-168043032	HepG2	liver:	n/a
13	chr2:168042982-168043032	GM12878	blood:	n/a
14	chr2:168042982-168043032	NH-A	brain:	n/a
15	chr2:168042982-168043032	Jurkat	blood:	n/a
16	chr2:168042982-168043032	T-47D	breast:	n/a
17	chr2:168042982-168043032	NHBE	bronchial:	n/a
18	chr2:168042982-168043032	HUVEC	blood vessel:	n/a
19	chr2:168042982-168043032	BE2_C	brain:	n/a
20	chr2:168042982-168043032	AG10803	skin:	n/a
21	chr2:168042982-168043032	PrEC	prostate:	n/a
22	chr2:168042982-168043032	SK-N-SH_RA	brain:	n/a
23	chr2:168042982-168043032	HCT-116	colon:	n/a
24	chr2:168042982-168043032	AG04450	lung:	fetal
25	chr2:168042982-168043032	AoSMC	blood vessel:	n/a
26	chr2:168042982-168043032	HCPEpiC	choroid plexus:	n/a
27	chr2:168042982-168043032	IMR90	lung:	fetal
28	chr2:168042982-168043032	SK-N-MC	brain:	n/a
29	chr2:168042982-168043032	K562	blood:	n/a
30	chr2:168042982-168043032	Caco-2	colon:	n/a
31	chr2:168042982-168043032	LNCaP	prostate:	n/a
32	chr2:168042982-168043032	SK-N-SH	brain:	n/a
33	chr2:168042982-168043032	GM12892	blood:	n/a
34	chr2:168042982-168043032	HEK293	kidney:	embryo
35	chr2:168042982-168043032	H1-hESC	embryonic stem cell:	embryo
36	chr2:168042982-168043032	HIPEpiC	eye:	n/a
37	chr2:168042982-168043032	HRCEpiC	kidney:	n/a
38	chr2:168042982-168043032	HL-60	blood:	n/a
39	chr2:168042982-168043032	RPTEC	kidney:	n/a
40	chr2:168042982-168043032	Hela-S3	cervix:	n/a
41	chr2:168042982-168043032	MCF10A-Er-Src	breast:	n/a
42	chr2:168042982-168043032	GM06990	blood:	n/a
43	chr2:168042982-168043032	ovcar-3	ovarian:	n/a
44	chr2:168042982-168043032	AG04449	skin:	fetal
45	chr2:168042982-168043032	HNPCEpiC	eye:	n/a
46	chr2:168042982-168043032	CMK	blood:	n/a
47	chr2:168042982-168043032	NT2-D1	testis:	n/a
48	chr2:168042982-168043032	HRE	kidney:	n/a
49	chr2:168042982-168043032	HEEpiC	esophagus:	n/a
50	chr2:168042982-168043032	AG09309	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:167983370..167984614-chr2:168068319..168069263,7	MCF-7	breast:
2	chr2:167756038..167756919-chr2:168067506..168068023,2	MCF-7	breast:
3	chr2:168023901..168026425-chr2:168026943..168029615,2	MCF-7	breast:
4	chr2:167756662..167757417-chr2:168068497..168069226,3	MCF-7	breast:
5	chr2:168023901..168026425-chr2:168026943..168029615,2	MCF-7	breast:
6	chr2:167395585..167396612-chr2:168068492..168069153,3	MCF-7	breast:
7	chr2:168039379..168041883-chr2:168796886..168798758,2	K562	blood:

Variant related genes	Relation type
XIRP2	TF binding region
XIRP2	CpG island
ENSG00000235335	chromatin interactions

Extended variants
information (count: 2049 )
Associated
traits (count: 47 )

Variant overlapped rSNPs/rCNVs (count:2049 , 50 per page) page: 1 2 3 4 5 6 7 ... 41

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10196588	chr2:168024328-168024329	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs527832943	chr2:168024359-168024360	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs73021981	chr2:168024415-168024416	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs371844088	chr2:168024440-168024441	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs73021983	chr2:168024464-168024465	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs190668470	chr2:168024520-168024521	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs569315948	chr2:168024533-168024534	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs76969319	chr2:168024563-168024564	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs569303427	chr2:168024579-168024580	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs531953251	chr2:168024688-168024689	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs139381801	chr2:168024726-168024727	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs565790603	chr2:168024800-168024801	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs116442019	chr2:168024801-168024802	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs372851126	chr2:168024823-168024824	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551871090	chr2:168024832-168024833	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs142564981	chr2:168024917-168024918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs75737574	chr2:168024973-168024974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs182549250	chr2:168024989-168024990	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs557332768	chr2:168025010-168025011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs576463689	chr2:168025081-168025082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs60789884	chr2:168025099-168025100	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs558752055	chr2:168025138-168025139	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs143995292	chr2:168025147-168025148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs375035848	chr2:168025153-168025154	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs112330596	chr2:168025155-168025156	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs561121012	chr2:168025168-168025169	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs112937476	chr2:168025177-168025178	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs111963932	chr2:168025189-168025190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs113027543	chr2:168025196-168025197	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs187250032	chr2:168025210-168025211	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs552167929	chr2:168025232-168025233	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs191871943	chr2:168025268-168025269	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs184395871	chr2:168025285-168025286	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs144587938	chr2:168025298-168025299	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs568251421	chr2:168025334-168025335	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs537252342	chr2:168025344-168025345	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs550845785	chr2:168025347-168025348	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs187727458	chr2:168025357-168025358	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs193248455	chr2:168025360-168025361	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs573401105	chr2:168025367-168025368	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs542302243	chr2:168025372-168025373	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs560937726	chr2:168025373-168025374	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs376934925	chr2:168025384-168025385	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs147963218	chr2:168025409-168025410	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs73021984	chr2:168025413-168025414	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs554655993	chr2:168025414-168025415	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs574648014	chr2:168025439-168025440	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs35234248	chr2:168025542-168025543	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs78456957	chr2:168025545-168025546	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs77821843	chr2:168025584-168025585	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:47)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Mental retardation	22214275	CNVD
Glioblastoma	21080181	CNVD
small cell lung cancer	20016488	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	18414403	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	16573809	CNVD
Myelofibrosis	22110671	CNVD
Neonatal seizures	20384724	CNVD
severe myoclonic epilepsy of infancy	18294202	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD

Chromatin state (count:453 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:168016200-168034200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr2:168024400-168024800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr2:168024400-168025000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr2:168024600-168025000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr2:168024600-168025200	Enhancers	Primary hematopoietic stem cells short term culture	blood
6	chr2:168025000-168026000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr2:168026000-168026200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr2:168030000-168030400	ZNF genes & repeats	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr2:168030400-168032200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr2:168032000-168032600	Enhancers	Gastric	stomach
11	chr2:168032200-168032400	ZNF genes & repeats	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr2:168032600-168037600	Weak transcription	Gastric	stomach
13	chr2:168033200-168033400	Enhancers	Muscle Satellite Cultured Cells	--
14	chr2:168033200-168033600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr2:168033200-168033800	Enhancers	HSMM	muscle
16	chr2:168033200-168035400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr2:168033400-168033600	Enhancers	NHLF	lung
18	chr2:168033400-168033800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
19	chr2:168033400-168034000	Enhancers	NHDF-Ad	bronchial
20	chr2:168033400-168034200	Enhancers	Osteobl	bone
21	chr2:168033400-168034400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr2:168033400-168035000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr2:168033400-168035400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr2:168033600-168034600	Weak transcription	NHLF	lung
25	chr2:168033800-168034200	Weak transcription	HSMM	muscle
26	chr2:168033800-168035400	Enhancers	Muscle Satellite Cultured Cells	--
27	chr2:168034000-168034400	Weak transcription	NHDF-Ad	bronchial
28	chr2:168034200-168034400	Enhancers	HSMM	muscle
29	chr2:168034200-168034800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr2:168034200-168037400	Weak transcription	Osteobl	bone
31	chr2:168034400-168034600	Enhancers	NHDF-Ad	bronchial
32	chr2:168034400-168037400	Weak transcription	HSMM	muscle
33	chr2:168034400-168038600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr2:168034600-168035400	Enhancers	NHLF	lung
35	chr2:168034600-168037400	Weak transcription	NHDF-Ad	bronchial
36	chr2:168034800-168037200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr2:168035000-168037400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr2:168035400-168036400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr2:168035400-168037000	Weak transcription	Muscle Satellite Cultured Cells	--
40	chr2:168035400-168037200	Weak transcription	NHLF	lung
41	chr2:168035400-168037400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr2:168036400-168039000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr2:168037000-168037400	Enhancers	Muscle Satellite Cultured Cells	--
44	chr2:168037200-168038000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr2:168037200-168038800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr2:168037200-168039000	Enhancers	NHEK	skin
47	chr2:168037200-168039200	Enhancers	HMEC	breast
48	chr2:168037200-168039200	Enhancers	NHLF	lung
49	chr2:168037400-168037800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
50	chr2:168037400-168038400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links